AGP Executive Report
Last update: 7 hours agoCBD/Insomnia Watch: Avecho is set to report interim results from its phase III synthetic CBD insomnia trial (about 520 patients; 75mg/150mg vs placebo for 8 weeks), aiming for an OTC path. Medical Cannabis in Care: Oncology Nursing News highlights medical cannabis as a “multimodal” option to ease multiple cancer symptoms while reducing pill burden for patients. Pain Research: A report says a cannabis compound may relieve pain without the high, and another story points to cannabis aroma compounds for chronic pain relief. Sleep + CBD/CBG Products: A UK lifestyle piece spotlights KLORIS Sleep Patches, claiming melatonin-free support with CBD/CBG plus calming botanicals. Enforcement + Seizures: India’s IGI Airport seized 13.84kg hydroponic weed worth ~₹4.83 crore and arrested a passenger; NDLEA in Nigeria arrested two grandpas accused of selling opioids to secondary school students. Policy + Legal Reality: Wisconsin guidance reiterates marijuana remains illegal in-state even if bought elsewhere, while CBD is legal; North Carolina’s cannabis ballot push faces GOP resistance. Safety + Community: A pet-safety roundup urges keeping dogs/cats home during fireworks stress.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.